Purple Biotech begins subject dosing in pancreatic cancer therapy trial
15 Feb 2023 //
CLINICAL TRIALS ARENA
Purple snags Immunorizon`s tri-specific antibodies in small M&A
02 Feb 2023 //
FIERCE BIOTECH
Purple Biotech Appoints Lior Fhima as CFO
02 Nov 2022 //
GLOBENEWSWIRE